Linked Life Data

10986004

Source:http://linkedlifedata.com/resource/pubmed/id/10986004

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2000-11-7
pubmed:abstractText
Vagal nerve stimulation using an NCP (Cyberonics) device has been suggested as a potential treatment for patients with epilepsy that has previously proven refractory. Ten patients in Northern Ireland have had this device implanted and been fully audited pre- and post-operatively. Twelve months post-implantation, five patients have demonstrated a greater than 50% reduction in seizure frequency. A statistical reduction in seizure severity of the ictal phase of the major seizures has also been shown. Improvement in the patients' overall quality of life has, however, not been demonstrated in parallel to seizure reduction.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1059-1311
pubmed:author
pubmed:copyrightInfo
Copyright 2000 BEA Trading Ltd.
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
442-5
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Vagal nerve stimulation in patients with refractory epilepsy. Effect on seizure frequency, severity and quality of life.
pubmed:affiliation
Directorate of Neurosciences, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BA, UK.
pubmed:publicationType
Journal Article